Closely linked polymorphic markers for determining the autosomal dominant allele (Cy) in rat polycystic kidney disease

被引:10
|
作者
Nagao, S [1 ]
Ushijima, T
Kasahara, M
Yamaguchi, T
Kusaka, M
Matsuda, J
Nagao, M
Takahashi, H
机构
[1] Fujita Hlth Univ, Inst Comprehens Med Sci, Lab Anim Ctr, Aichi 4701192, Japan
[2] Natl Canc Ctr, Res Inst, Cacinogenesis Div, Chuo Ku, Tokyo 1040045, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pathol, Aichi 4701192, Japan
关键词
polycystic kidney; polymorphism; rat; Cy; gene;
D O I
10.1023/A:1018742807031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Han:SPRD strain is an SD-background strain known to be a model of polycystic kidney disease (PKD) expressed through an autosomal dominant gene (Cy). However, different genotypes of this strain cannot be identified in the neonatal period. First, to establish an accurate method of determining the genotypes (Cy/Cy, Cy/+, +/+) which cause different disease progressions, we used polymorphic markers on rat chromosome 5. PCR products of tissue DNA templated with D5Rat9 showed distinct patterns on electrophoresis indicating three genotypes. Second, to determine whether the same locus plays a major role in expressing PKD, we performed linkage analyses ina a [BN x (BN x Han:SPRD)F-1] backcross. Cy/Cy and Cy/+ also caused PKD in a BN background. In this backcross, we discovered that D5Rat11 is located closer to the Cy locus than DSMgh10, which is regarded as one of the closest loci. We conclude that D5Rat9 and D5Rat11 are useful markers for deter-mining the presence of the Cy allele, which is regarded as the gene responsible for PKD.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [41] Autosomal Dominant Polycystic Kidney Disease in Children
    Patro, Kiran Chandra
    Dilip, R.
    Ramakrishnan, S.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (06) : 1242 - 1245
  • [42] Hypertension in Autosomal Dominant Polycystic Kidney Disease
    Chapman, Arlene B.
    Stepniakowski, Konrad
    Rahbari-Oskoui, Frederic
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 153 - 163
  • [43] Hypertension and Autosomal Dominant Polycystic Kidney Disease
    Schrier, Robert W.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (06) : 811 - 813
  • [44] Autosomal-dominant polycystic Kidney Disease
    Wuethrich, R. P.
    NEPHROLOGE, 2015, 10 (05): : 376 - 378
  • [45] NEPHROLITHIASIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Ristovska, V.
    Grcevska, L.
    Popovska, M. M.
    Nikolov, V.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2011, 34 (08): : 650 - 650
  • [46] Angiogenesis and autosomal dominant polycystic kidney disease
    Huang, Jennifer L.
    Woolf, Adrian S.
    Long, David A.
    PEDIATRIC NEPHROLOGY, 2013, 28 (09) : 1749 - 1755
  • [47] MRI in autosomal dominant polycystic kidney disease
    Zhang, Weiguo
    Blumenfeld, Jon D.
    Prince, Martin R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 50 (01) : 41 - 51
  • [48] Autosomal Dominant Polycystic Kidney Disease A Review
    Chebib, Fouad T.
    Hanna, Christian
    Harris, Peter C.
    Torres, Vicente E.
    Dahl, Neera K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [49] The Treatment of Autosomal Dominant Polycystic Kidney Disease
    Kuehn, E. Wolfgang
    Walz, Gerd
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (51-52): : 884 - 890
  • [50] Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
    Spital, Aaron
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1257 - 1257